These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 19004140)
21. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008. Kuznik A; Mardekian J Cardiovasc Diabetol; 2011 Apr; 10():31. PubMed ID: 21496321 [TBL] [Abstract][Full Text] [Related]
22. [Continuing care of patients with cardiovascular risk in general practice: diabetic patients and their care]. Ilyés I; Jancsó Z; Kovács E; Márton H; Simay A Orv Hetil; 2005 Dec; 146(51):2581-8. PubMed ID: 16468612 [TBL] [Abstract][Full Text] [Related]
23. Trends in cardiovascular risk factors among U.S. men and women with and without diabetes, 1988-2014. Sun X; Du T BMC Public Health; 2017 Nov; 17(1):893. PubMed ID: 29166886 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Gupta A; Gupta R; Sarna M; Rastogi S; Gupta VP; Kothari K Diabetes Res Clin Pract; 2003 Jul; 61(1):69-76. PubMed ID: 12849925 [TBL] [Abstract][Full Text] [Related]
25. The impact of point of care testing on diabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program. Shephard MD; Mazzachi BC; Shephard AK; McLaughlin KJ; Denner B; Barnes G Rural Remote Health; 2005; 5(3):371. PubMed ID: 16026194 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305 [TBL] [Abstract][Full Text] [Related]
27. The relationship between high-density lipoprotein cholesterol (HDL-C) and glycosylated hemoglobin in diabetic patients aged 20 or above: a cross-sectional study. Huang R; Yan L; Lei Y BMC Endocr Disord; 2021 Oct; 21(1):198. PubMed ID: 34635098 [TBL] [Abstract][Full Text] [Related]
28. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens; 1993 Mar; 11(3):309-17. PubMed ID: 8387089 [TBL] [Abstract][Full Text] [Related]
29. EPIDEMIOLOGY OF DIABETES AND IMPAIRED FASTING GLUCOSE IN A RURAL COMMUNITY OF NIGERIAN NIGER DELTA REGION. Alikor CA; Emem-Chioma PC Niger J Med; 2015; 24(2):114-24. PubMed ID: 26353421 [TBL] [Abstract][Full Text] [Related]
30. Sex Differences in Cardiovascular Risk Factors among People with Diabetes in South India. Satyavani K; Archana S; Kumar AM; Achanta S; Viswanathan V J Assoc Physicians India; 2015 Dec; 63(12):20-24. PubMed ID: 27666899 [TBL] [Abstract][Full Text] [Related]
31. Observational study of effects of Saroglitazar on glycaemic and lipid parameters on Indian patients with type 2 diabetes. Chatterjee S; Majumder A; Ray S Sci Rep; 2015 Jan; 5():7706. PubMed ID: 25573251 [TBL] [Abstract][Full Text] [Related]
32. [Cardiovascular risk factor control in a population with longstanding diabetes attending endocrinology departments]. Comi-Diaz C; Miralles-García JM; Cabrerizo L; Pérez M; Masramon X; De Pablos-Velasco P; Endocrinol Nutr; 2010 Dec; 57(10):472-8. PubMed ID: 21115412 [TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and complications of patients with type 2 diabetes attending an urban hospital in Bangladesh. Islam SM; Alam DS; Wahiduzzaman M; Niessen LW; Froeschl G; Ferrari U; Seissler J; Rouf HM; Lechner A Diabetes Metab Syndr; 2015; 9(1):7-13. PubMed ID: 25450814 [TBL] [Abstract][Full Text] [Related]
35. Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients. Bastard JP; Couffignal C; Fellahi S; Bard JM; Mentre F; Salmon D; Katlama C; Raffi F; Leport C; Capeau J; Diabetes Metab; 2019 Dec; 45(6):573-581. PubMed ID: 30862472 [TBL] [Abstract][Full Text] [Related]
36. [Glucose metabolism disorders in the risk factor control in Extremadura Study (COFRE Study)]. Robles NR; Marcos G; Barroso S; Sánchez Muñoz-Torrero JF; Endocrinol Nutr; 2010 Apr; 57(4):147-54. PubMed ID: 20347406 [TBL] [Abstract][Full Text] [Related]
37. TRADITIONAL CARDIOVASCULAR RISK-FACTORS AMONG HEALTHCARE WORKERS IN KELANTAN, MALAYSIA. Hazmi H; Ishak WR; Jalil RA; Hua GS; Hamid NF; Haron R; Shafei MN; Ibrahim MI; Bebakar WM; Ismail SB; Musa KI Southeast Asian J Trop Med Public Health; 2015 May; 46(3):504-11. PubMed ID: 26521525 [TBL] [Abstract][Full Text] [Related]
38. The Relationship Between Glycaemic Control and Non-Alcoholic Fatty Liver Disease in Nigerian Type 2 Diabetic Patients. Afolabi BI; Ibitoye BO; Ikem RT; Omisore AD; Idowu BM; Soyoye DO J Natl Med Assoc; 2018 Jun; 110(3):256-264. PubMed ID: 29778128 [TBL] [Abstract][Full Text] [Related]
39. [Diabetes control in type 2 diabetic subjects treated in primary health care]. Fabian W; Majkowska L; Moleda P; Stefański A Pol Arch Med Wewn; 2006 Aug; 116(2):760-5. PubMed ID: 17424921 [TBL] [Abstract][Full Text] [Related]
40. Prevalence of lipid and glycaemic abnormalities in hypertensive patients: a retrospective survey. Joglekar SJ; Nanivadekar AS Indian Heart J; 1996; 48(4):371-4. PubMed ID: 8908824 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]